Feature | Nuclear Imaging | November 05, 2019 | Dave Fornell, Editor

Philips Forte Gamma Camera Recalled for Possibility of Crushing Patient

Older SPECT camera is under a Class I recall

Philips Medical System is recalling its older Forte Gamma Camera SPECT imaging systems due to the possibility of the detectors falling off of the unit onto the patient. The two gamma cameras can bee seen in this photo on either side of the patient bed. These can be rotated above the patient.

Philips Medical System is recalling its older Forte Gamma Camera SPECT imaging systems due to the possibility of the detectors falling off of the unit onto the patient. The two gamma cameras can be seen in this photo on either side of the patient bed. These can be rotated above the patient.

November 5, 2019 — Philips Medical System is recalling the Forte Gamma Camera System due to the potential for the 660-pound detector to detach from the device without warning. The vendor said this could result in a serious injury, such as crushing, trapping or killing the patient. The U.S. Food and Drug Administration (FDA) reported Philips received one customer complaint, but no serious injuries or deaths were reported.

The FDA said this is a Class I recall, due to potential for the nuclear imaging detector to become detached, which can result in injury or death. Philips told its customers to discontinue use of the Forte Gamma Camera System until further notice. Philips initiated its recall Sept. 19, 2019. It includes 852 devices recalled in the United States.

The FDA and Philips are taking precautions because of a June 2013 accident, when the detector on a GE Healthcare SPECT system fell onto a patient and killed them during a scan at the James J. Peters VA Medical Center in the Bronx, N.Y. That incident resulted in a similar recall at the time for GE's nuclear imaging systems. Read the article Patient Killed During Nuclear Imaging Scan.

The Forte Gamma Camera System is an older single photon emission computed tomography (SPECT) nuclear imaging system. These systems were manufactured between Jan. 1, 1998 and Dec. 31, 2008. It is used to create images of structures or functions inside the body of patients using a radioisotope tracer to diagnose, plan treatment and evaluate many conditions, including cancer and cardiac perfusion.

The recalled products include the following imaging system:
   • Philips Medical System Forte Gamma Camera System
   • Forte (882020)
   • Forte Jetstream (882290)
   • Forte Jetstream upgrade (882291)
   • Forte Jetstream AZ (882320)
   • Forte Jetstream AZ upgrade (882321)
   • Diamond Select Forte (889456)
   • Diamond Select Forte JETStream (889471)

A portion of the gamma camera head weight comes from the heavy lead collimators built into them. 

Philips sent a letter to customers who purchased the affected systems and provided the following instructions:
   • Discontinue use of the Forte Gamma Camera System until further notice
   • Maintain the letter with the Forte Gamma Camera System until a correction is made to the system
   • Complete the Customer Response Form and e-mail it to [email protected]

Healthcare providers and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program. Complete and submit the report online. Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the form, or submit by fax to 1-800-FDA-0178.

Access original FDA recall notice
 

Related Content

Gallium-68 from GalliaPharm is used for the preparation of diagnostic imaging drugs in Positron Emission Tomography (PET).
News | PET Imaging | September 03, 2021
September 3, 2021 — Eckert & Ziegler Radiopharma GmbH has successfully submitted an amendment to their Drug Maste
ASTRO’s 63rd Annual Meeting is scheduled to take place as an in-person meeting October 24-27 in Chicago, but be sure to bring along your masks

Getty Images

News | ASTRO | August 11, 2021
August 11, 2021 — ASTRO announced that it is facilitating measu
Cerium-134 can be targeted to provide an imaging analogue for two different therapy isotopes, actinium-225 and thorium-227. This helps scientists understand these therapy isotopes and develop new treatments. Image courtesy of Donald Montoya, Los Alamos National Laboratory

Cerium-134 can be targeted to provide an imaging analogue for two different therapy isotopes, actinium-225 and thorium-227. This helps scientists understand these therapy isotopes and develop new treatments. Image courtesy of Donald Montoya, Los Alamos National Laboratory

News | PET Imaging | August 06, 2021
August 6, 2021 — A multidisciplinary tea...
PET, PET imaging, PET-CT, FDG PET, PET cancer assessment, pet scanner, nuclear imaging, molecular imaging

A PET-CT head and neck cancer scan showing various image reconstructions. The top left image is the separate CT scan showing the anatomy. The top right scan shows the fused PET and CT scans with false color added to help interpret the image. The bottom left scan is an initial FDG PET image showing tracer hot spots in the neck and a lymph node in the right jaw due to cancer. The right bottom image is a delayed enhancement scan showing tracer uptake over time, with normal hot spots in the bladder, kidneys, testicles and brain, which normally have higher metabolic activity. The low-grade gray shading of the anatomy is due to the normal cellular metabolism uptake of the FDG throughout the body. 

News | PET-CT | August 04, 2021
August 4, 2021 — PET/CT systems are exp
The Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR), along with physicians and patient organizations, supports the introduction of H.R. 4479, the “Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021” by Congressmen Scott Peters (D-CA), Bobby Rush (D-IL), Neal Dunn (R-FL) and Greg Murphy (R-NC).

Getty Images

News | Nuclear Imaging | August 04, 2021
August 4, 2021 — The Council on Radionuclides and Radiopharmaceuticals, Inc.

Image courtesy of Vital Images

News | Molecular Imaging | August 02, 2021
August 2, 2021 — The global molecular imaging marke
The FLASH Effect significantly improves the therapeutic ratio for curing cancer

The FLASH Effect significantly improves the therapeutic ratio for curing cancer

News | Radiation Oncology | July 28, 2021
July 28, 2021 — IntraOp Medical Corporation announced that ...